Amphiregulin as a novel diagnostic and prognostic biomarker of hepatocellular carcinoma before and after locoregional treatment
Abstract Background Hepatocellular carcinoma is a highly prevalent tumor worldwide. Amphiregulin is a ligand of the epidermal growth factor receptor. Its elevation is linked to different inflammatory and neoplastic conditions. Therefore, amphiregulin may represent a potential diagnostic target in HC...
Enregistré dans:
Auteurs principaux: | Amira Isaac, Sherif Mounir Mohamed, Osama Ashraf Ahmed, Ahmed Gamal Mohamed Hassan, Hany Samir Rasmy |
---|---|
Format: | article |
Langue: | EN |
Publié: |
SpringerOpen
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/7eb938a4cc2b4c24b7e6e32a4cc6c076 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Transcatheter chemoembolization plus percutaneous radiofrequency ablation versus laparoscopic radiofrequency ablation: improved outcome for inoperable hepatocellular carcinoma
par: Bin Chai, et autres
Publié: (2021) -
Contrast-enhanced Ultrasound Assessment of Treatment Response in a Patient with Multifocal Hepatocellular Carcinoma Treated with Transarterial Chemo and Radioembolization
par: Esika Savsani, Mohamed Tantawi, MD, Corinne E. Wessner, MBA, RDMS, RVT, Philip Lee, MD, Andrej Lyshchik, MD, PhD, Kevin Anton, MD, PhD, Colette M. Shaw, MD, Ji-Bin Liu, MD, John R. Eisenbrey, PhD
Publié: (2021) -
Early experience with laparoscopic treatment of liver tumors using a separable cluster electrode with a no-touch technique
par: Hyun Hong, et autres
Publié: (2020) -
Development of a Model to Predict Liver Decompensation prior to Transarterial Chemoembolization Refractoriness in Patients with Intermediate-Stage Hepatocellular Carcinoma
par: Joel Ferreira-Silva, et autres
Publié: (2021) -
Hyperthermia ablation combined with transarterial chemoembolization versus monotherapy for hepatocellular carcinoma: A systematic review and meta‐analysis
par: Zheng Li, et autres
Publié: (2021)